epipen Archives - MedCity News

FDA Rejects ARS Pharma’s Nasal Spray Alternative to Injectable Epinephrine

Frank Vinluan — Wed, 20 Sep 2023 17:51:20 +0000

ARS Pharmaceuticals frames its intranasal epinephrine spray as a needle-free alternative to products such as EpiPen. Though this spray won the backing of an FDA advisory committee, the agency is now requiring that ARS Pharma run another study to support a regulatory submission.

EpiPen, often chided for high price, gets first generic competitor

Alaric DeArment — Thu, 16 Aug 2018 19:09:25 +0000

The drugmaker’s generic had originally met with FDA rejection in early 2016, amid a national debate over EpiPen’s price.

Why did Mylan invest in coal plants?

Juliet Preston — Fri, 23 Jun 2017 00:12:05 +0000

Mylan evidently subscribes to a “living in the gray” mentality when it comes to business operations.

Is Mylan’s EpiPen reign finally over?

Juliet Preston — Fri, 16 Jun 2017 06:16:57 +0000

A healthy dose of competition has been injected into the market for life-saving emergency epinephrine injectors.

Mylan settles EpiPen Medicaid rebate case for $465M, stock jumps

Neil Versel — Fri, 07 Oct 2016 22:45:38 +0000

Mylan settled with the U.S. Department of Justice to head off potential Medicaid liability claims by federal and state governments.

Runaway cost of EpiPens hits taxpayers right in their Medicare

Julie Applebee and Mary Agnes Carey — Thu, 22 Sep 2016 16:05:36 +0000

The abrupt rise is notable because many people think that life-threatening allergies are less common among the elderly. In addition, epinephrine — the active ingredient in EpiPens — can pose greater risks to older adults.

Jimmy Kimmel disses EpiPen during Emmy Awards

Arundhati Parmar — Mon, 19 Sep 2016 05:02:40 +0000

Jimmy Kimmel makes a timely joke about EpiPen during the 68th Annual Emmy Awards he was hosting Sunday night.

How Mylan cornered the consumer epinephrine market

Pauline Bartolone — Thu, 08 Sep 2016 19:29:33 +0000

High-profile deaths in several states have helped to spur legislative action and fuel demand for consumer-dispensed epinephrine. At the same time, no other company has been able to effectively compete with Mylan’s EpiPen.

EpiPen is just tip of the iceberg for FDA generic drug backlog

Sydney Lupkin — Tue, 06 Sep 2016 15:00:00 +0000

Critics say getting generic alternatives to the U.S. market for products like EpiPen is still taking far too long.

Five most-read stories of the week

Arundhati Parmar — Sat, 27 Aug 2016 11:50:17 +0000

From Apple’s acquisition of Gliimpse to the story behind Bristol-Myers Squibb’s failed Opdivo immunotherapy drug, here were the most-read stories of the week.

Now, the gloves are off in the EpiPen saga

Neil Versel — Wed, 24 Aug 2016 23:17:14 +0000

The maker of EpiPen, the life-saving auto-injector for anaphylaxis, is under fire for exorbitant price hikes so much so that even Martin Shkreli called Mylan out for price-gouging last week.

Windgap Medical – making progress toward an alternative to the EpiPen

Nicole Oran — Fri, 05 Feb 2016 17:21:25 +0000

Windgap Medical is moving forward in its development of its EpiPen alternative device with two newly solidified patents.

Innovation is in progress to replace the bulky EpiPen with something more practical

Nicole Oran — Wed, 02 Sep 2015 13:00:58 +0000

There must be some better, more efficient solutions for the essential use of the EpiPen, and Windgap Medical is working on it.

Watch out, EpiPen: A better auto-injector for severe allergies is in the works

Meghana Keshavan — Tue, 02 Jun 2015 02:45:21 +0000

As allergies rise, so does the need for on-the-spot epinephrine treatment. Windgap Medical wants to win a chunk of this fast-growing, $1.3 billion market.